Skip to main content
SpringerLink
Log in

Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer

  • Chapter
  • First Online:
Book cover Cervical Cancer

  • 2601 Accesses

Abstract

In patients with locally recurrent cervical cancer, pelvic exenteration is a viable option with long-term survival in over one third of patients. Depending on the survival disease-free, the site and size of recurrence can be set 5-year survivals of 48–60%. Since it was first reported in 1948, pelvic exenteration has been used in the treatment of advanced pelvic cancers. The original procedure has been modified in an attempt to preserve urinary or fecal continence. The subclassification of the exenteration groups into type I (supralevator), type II (infralevator), and type III (with vulvectomy) is helpful to facilitate understanding of the extent of resection of the pelvic structures and the anatomical changes associated with each operation. Pelvic exenteration should only be undertaken by experienced surgeons at specialized centers. Restorative techniques for both urinary and gastrointestinal tracts can diminish the need for stomas and, along with vaginal reconstruction, can significantly improve quality of life for many patients afterexenteration. These advances in surgery and radiotherapy help make the procedure a viable option for patients with otherwise incurable elvic malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Höckel M, Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol. 2006;7(10):837–47.

    Article  PubMed  Google Scholar 

  2. Brunschwig A. Complete excision of pelvic viscera for abdominal carcinoma. Cancer. 1948;1:177–88.

    Article  CAS  PubMed  Google Scholar 

  3. Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin North Am. 1950;30:1511–21.

    Article  CAS  PubMed  Google Scholar 

  4. Brunschwig A. What are the indications and results of pelvic exenteration? JAMA. 1965;194(3):274.

    Article  CAS  PubMed  Google Scholar 

  5. Brunschwig A, Barber HRK. Pelvic exenteration combined with resection of segments of bony pelvis. Surgery. 1969;65:417–20.

    CAS  PubMed  Google Scholar 

  6. Magrina JF. Types of pelvic exenterations: a reappraisal. Gynecol Oncol. 1990;37:363–6.

    Article  CAS  PubMed  Google Scholar 

  7. Sevin B-U. Pelvic exenteration. Surg Clin North Am. 2001;81(4):771–80.

    Article  CAS  PubMed  Google Scholar 

  8. Kaur M, Joniau S, D’Hoore A, Vergote I. Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy. Curr Opin Oncol. 2014;26(5):514–20.

    Article  PubMed  Google Scholar 

  9. Buchsbaum HJ, White AJ. Omental sling for management of the pelvic floor following exenteration. Am J Obstet Gynecol. 1973;117:407–12.

    Article  CAS  PubMed  Google Scholar 

  10. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol. 1989;35:93–8.

    Article  CAS  PubMed  Google Scholar 

  11. Magrina JF et al. Pelvic Exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol. 1997;64:130–5.

    Article  CAS  PubMed  Google Scholar 

  12. Baiocchi G, Guimaraes GC, Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A. Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncol. 2012;38(10):948–54.

    Article  CAS  PubMed  Google Scholar 

  13. Peiretti M et al. Management of recurrent cervical cancer: a review of the literature. Surg Oncol. 2012;21(2):59–66.

    Article  Google Scholar 

  14. Landoni F et al. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience. Gynecol Oncol. 2013;130(1):69–74.

    Article  CAS  PubMed  Google Scholar 

  15. Iglesias DA et al. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol. 2012;125:336–42.

    Article  PubMed  Google Scholar 

  16. Huang M, Iglesias DA, Westin SN, et al. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014;132:114–8.

    Article  PubMed  Google Scholar 

  17. Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol. 2001;76:224–36.

    Article  CAS  PubMed  Google Scholar 

  18. Kaur M, Joniau S, et al. Pelvic exenteration for gynecological malignancies: a study of 36 cases. Int J Gynecol Cancer. 2012;22:889–96.

    Article  PubMed  Google Scholar 

  19. Vargas H. Magnetic resonance imagin/ positron emission tomography provides a roadmap for surgical planning and serves as predictive biomarker in patients with recurrent gynecological cancer undergoing pelvic exenteration. Int J Gynecol Cancer. 2013;23(8):1512–9.

    Article  PubMed  Google Scholar 

  20. Rutledge FN, McGuffee VB. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol. 1987;26(3):374–80.

    Article  CAS  PubMed  Google Scholar 

  21. Schmidt AM, Imesch P, Fink D, Egger H. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol. 2012;25(3):604–9.

    Article  Google Scholar 

  22. Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99:153–9.

    Article  PubMed  Google Scholar 

  23. Höckel M, Horn LC, Einenkel J. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecol Oncol. 2012;127(2):297–302.

    Article  PubMed  Google Scholar 

  24. Köhler C, Tozzi R, Possover M, Schneider A. Explorative laparoscopy prior to exenterative surgery. Gynecol Oncol. 2002;86(3):311–5.

    Article  PubMed  Google Scholar 

  25. Westin SN, Rallapalli V, Fellman B. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134(3):546–51.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Jurado M, Alcázar JL, Martinez-Monge R. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience. Gynecol Oncol. 2010;116(1):38–43.

    Article  PubMed  Google Scholar 

  27. Höckel M. Laterally extended endopelvic resection (LEER)--principles and practice. Gynecol Oncol. 2008;111(2 Suppl):S13–7.

    Article  PubMed  Google Scholar 

  28. Chiantera V, Rossi M, De Laco P. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer. 2014;24(1):156–64.

    Article  PubMed  Google Scholar 

  29. Martínez A, Filleron T, Vitse L, Querleu D. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol. 2011;120(3):374–9.

    Article  PubMed  Google Scholar 

  30. Puntambekar S, Rajamanickam S. Laparoscopic posterior exenteration in advanced gynecologic malignant disease. J Minim Invasive Gynecol. 2011;18(1):59–63.

    Article  PubMed  Google Scholar 

  31. Hatch KD, Gelder MS, Soong SJ, et al. Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol Oncol. 1990;38:462–7.

    Article  CAS  PubMed  Google Scholar 

  32. Moutardier V, Houvenaeghel G, Lelong B. Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series. Gynecol Oncol. 2003;89(1):155–9.

    Article  CAS  PubMed  Google Scholar 

  33. Madersbacher S, Schmidt J, Eberle JM. Long-term outcome of ileal conduit diversion. J Urol. 2003;169(3):985–90.

    Article  PubMed  Google Scholar 

  34. Bloch WE, Bejany DE, Penalver MA, Politano VA. Complications of the Miami pouch. J Urol. 1992;147(4):1017–9.

    CAS  PubMed  Google Scholar 

  35. Mirhashemi R, Im S, Yazdani T. Urinary diversion following radical pelvic surgery. Curr Opin Obstet Gynecol. 2004;16(5):419–22.

    Article  PubMed  Google Scholar 

  36. Salom EM, Mendez LE, Schey D, Lambrou N, Kassira N, Gómez-Marn O, Averette H, Peñalver M. Continent ileocolonic urinary reservoir (Miami pouch): the University of Miami experience over 15 years. Am J Obstet Gynecol. 2004;190(4):994–1003.

    Article  PubMed  Google Scholar 

  37. Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival. J Surg Oncol. 2007;96(7):560–8.

    Article  PubMed  Google Scholar 

  38. Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, Caceres A, Einstein MH, Abu-Rustum NR, Barakat RR, Makker V, Chi DS. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128(2):191–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Surgical Oncology, Instituto Nacional de Cancerología-México, Av. San Fernando No 22, Col. Sección XVI, Mexico City, zip code 14080, Mexico

    Gonzalo Montalvo-Esquivel MD, Angel Herrera-Gómez MD, Francisco Javier Alcalá-Prieto MD & Horacio Noé López Basave MD

  2. Gynecologic Tumors Deparment, Instituto Nacional de Cancerología-México, Mexico City, Mexico

    Milagros C. Pérez-Quintanilla MD

  3. Department Medical Oncology, Instituto Nacional de Cancerología-México, Mexico City, Mexico

    Flavia Morales-Vásquez MD

Authors
  1. Gonzalo Montalvo-Esquivel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Milagros C. Pérez-Quintanilla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angel Herrera-Gómez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francisco Javier Alcalá-Prieto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Flavia Morales-Vásquez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Horacio Noé López Basave MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gonzalo Montalvo-Esquivel MD .

Editor information

Editors and Affiliations

  1. Instituto Nacional de Cancerología, Mexico City, Mexico

    Jaime G. de la Garza-Salazar

  2. Instituto Nacional de Cancerología, Mexico City, Mexico

    Flavia Morales-Vásquez

  3. Instituto Nacional de Cancerología, Mexico City, Mexico

    Abelardo Meneses-Garcia

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Montalvo-Esquivel, G., Pérez-Quintanilla, M.C., Herrera-Gómez, A., Alcalá-Prieto, F.J., Morales-Vásquez, F., Basave, H.N.L. (2017). Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer. In: de la Garza-Salazar, J., Morales-Vásquez, F., Meneses-Garcia, A. (eds) Cervical Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-45231-9_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45231-9_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45230-2

  • Online ISBN: 978-3-319-45231-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation